Dr. Abate-Shen began her independent career at the Center for Advanced Biotechnology and Medicine, UMDNJ-Robert Wood Johnson Medical School (currently Rutgers Medical School). She rose quickly through the ranks and was appointed to Associate Professor with tenure in 1997, Professor in 2001, and Chief of the Division of Research in the Department of Medicine in 2002. In 1999, Dr. Abate-Shen founded the Prostate Program for The Cancer Institute of New Jersey and served as its co-leader until leaving UMDNJ. In September 2007, Dr. Abate-Shen was recruited to the faculty of Columbia University College of Physicians and Surgeons as Professor in the Departments of Urology and Pathology & Cell Biology at the Herbert Irving Comprehensive Cancer Center. In 2008, she was appointed Associate Director at the Herbert Irving Comprehensive Cancer Center, and in 2010 the Leader of its Prostate Program. She is currently the Interim Director at the Herbert Irving Comprehensive Cancer Center.
Dr. Abate-Shen’s research focuses on the molecular mechanisms linking cancer and development using in vivo models. Her work has led to the generation of mouse models of human cancer, which have provided important insights regarding mechanisms of tumorigenesis, as well as pre-clinical models for chemoprevention and chemotherapy. She has been the recipient of numerous awards, including a Sinsheimer Scholar Award, an NSF Young Investigator Award and the Women in Cell Biology Junior Award from the American Society for Cell Biology. She is an American Cancer Society Research Professor. Dr. Abate-Shen has been invited to present her work at more than fifty institutions and conferences in the United States and in Europe and has organized symposia, scientific conferences and “think tanks” for the American Association of Cancer Research (AACR), the Jackson Laboratories and the National Cancer Institute. Dr. Abate-Shen served on the Board of Scientific Counselors of the National Cancer Institute, as well as on its Blue Ribbon Panel Working Group. She has recently been elected to the American Association of Cancer Research Board of Directors.
« Go Back